TxCell S.A. | Ownership

Companies that own TxCell S.A.

Name
Shares Held
% Shares Out
Change In Shares
% of Assets
As of Date
Oddo BHF Asset Management SAS
1,150,000
4.96%
1,150,000
0.03%
07/04/2018
Heights Capital Management, Inc.
966,691
4.17%
0
0.08%
04/25/2018
Gestys SA
125,000
0.54%
0
5.34%
03/23/2018
Allianz Global Investors GmbH (France)
5,640
0.02%
2,051
0%
12/31/2015
Gutmann Finanz Strategien AG
4,300
0.02%
0
0.06%
09/30/2017
Aviva Investors Global Services Ltd.
0
0%
-32,468
0%
10/15/2017

About TxCell

View Profile
Address
Les Cardoulines HT1
Valbonne-Sophia Antipolis Rhone-Alpes 06560
France
Employees -
Website http://www.txcell.com/index.php/fr
Updated 09/14/2018
TxCell SA is a biotechnology company. The company engages in the research and development of cellular immunotherapy for chronic inflammatory and autoimmune diseases. Its pipeline consists of Ovasave, col treg, lupus, transplantation and car treg dermatology.